| Breakdown | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 273.60M | 383.10M | 332.35M | 462.25M | 378.78M |
| Gross Profit | 234.00K | 7.02M | 5.24M | 91.70M | 56.59M |
| EBITDA | -18.57M | -12.46M | -14.86M | 73.97M | 30.80M |
| Net Income | -18.91M | -12.86M | -15.33M | 62.19M | 28.70M |
Balance Sheet | |||||
| Total Assets | 369.07M | 395.26M | 373.37M | 416.24M | 362.52M |
| Cash, Cash Equivalents and Short-Term Investments | 31.45M | 78.56M | 112.05M | 147.75M | 55.99M |
| Total Debt | 13.00M | 13.06M | 5.31M | 10.33M | 15.14M |
| Total Liabilities | 126.41M | 133.68M | 98.94M | 101.58M | 85.14M |
| Stockholders Equity | 242.67M | 261.58M | 274.44M | 314.66M | 277.37M |
Cash Flow | |||||
| Free Cash Flow | -6.12M | -34.06M | -10.46M | 117.21M | 22.48M |
| Operating Cash Flow | -5.81M | -34.06M | -10.46M | 117.52M | 22.50M |
| Investing Cash Flow | 2.61M | 5.74M | 5.03M | 4.51M | 2.74M |
| Financing Cash Flow | -65.00K | -5.39M | -30.27M | -30.27M | -15.37M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | HK$245.69M | 1.74 | 11.27% | 13.51% | -32.40% | 671.43% | |
73 Outperform | HK$427.50M | 1.85 | 15.79% | 5.71% | -8.56% | 4.84% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
56 Neutral | HK$244.85M | 0.50 | 10.06% | ― | -17.67% | 1010.71% | |
48 Neutral | HK$216.00M | 5.92 | 4.36% | 15.38% | 0.39% | -42.36% | |
46 Neutral | HK$300.46M | -0.25 | -11.32% | ― | -8.54% | -25.17% | |
45 Neutral | HK$101.35M | -1.28 | -47.12% | ― | -70.99% | -2960.61% |